Page last updated: 2024-08-16
vigabatrin and s 1743
vigabatrin has been researched along with s 1743 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bhattaram, A; Earp, JC; Florian, J; Krudys, K; Lee, JE; Lee, JY; Liu, J; Mehrotra, N; Mulugeta, Y; Sinha, V; Yu, J; Zhao, P | 1 |
Reviews
1 review(s) available for vigabatrin and s 1743
| Article | Year |
|---|---|
Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
Topics: Adalimumab; Adolescent; Adolescent Development; Adult; Age Factors; Anti-HIV Agents; Anti-Inflammatory Agents; Anticonvulsants; Child; Child Development; Child, Preschool; Crohn Disease; Dose-Response Relationship, Drug; Drug Approval; Drug Dosage Calculations; Drug Labeling; Esomeprazole; Gastroesophageal Reflux; HIV Infections; Humans; Infant; Infant, Newborn; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Proton Pump Inhibitors; Seizures; Vigabatrin | 2016 |